tolbutamide has been researched along with Leukemia, Myeloid in 1 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, H | 1 |
| Slowik, R | 1 |
| Wache, HW | 1 |
1 other study available for tolbutamide and Leukemia, Myeloid
| Article | Year |
|---|---|
[Monocytic leukemia during long-term tolbutamide therapy].
Topics: Autopsy; Diabetes Complications; Diabetes Mellitus; Humans; Leukemia, Myeloid; Male; Middle Aged; Ti | 1970 |